
    
      This study is a Prospective, Multicenter Observational Post Market Release Study. It shall
      involve around 2,000 patients that are eligible for Implantable Cardiac Pacemakers (IPG)
      implantation, 500 patients eligible for Cardiac Resynchronization Pacemakers (CRT-P)
      implantation, 1,000 patients eligible for the implantation of Implantable Cardioverter
      Defibrillators with or without Cardiac Resynchronization Pacemakers (CDI, CRT-D), and around
      20 centers in Brazil. Patients will be consecutively enrolled in centers among those selected
      for the implantation of a Medtronic device in accordance with indications approved.
    
  